Half Yearly Results of AstraZeneca Pharma (in Rs. Cr.) |
Sep '20 |
Mar '20 |
Sep '19 |
Mar '19 |
Sep '18 |
|
Net Sales/Income from operations |
403.05 |
418.76 |
413.04 |
405.50 |
322.80 |
|
Other Operating Income |
-- |
-- |
-- |
-- |
-- |
|
Total Income From Operations |
403.05 |
418.76 |
413.04 |
405.50 |
322.80 |
|
EXPENDITURE |
|
|
|
|
|
|
Consumption of Raw Materials |
44.83 |
38.17 |
32.04 |
39.08 |
26.34 |
|
Purchase of Traded Goods |
116.41 |
163.97 |
110.26 |
122.48 |
47.36 |
|
Increase/Decrease in Stocks |
-11.12 |
-41.11 |
1.90 |
-33.77 |
32.38 |
|
Power & Fuel |
-- |
-- |
-- |
-- |
-- |
|
Employees Cost |
111.99 |
133.80 |
102.90 |
112.52 |
88.02 |
|
Depreciation |
9.18 |
9.32 |
9.27 |
7.69 |
7.22 |
|
Excise Duty |
-- |
-- |
-- |
-- |
-- |
|
Admin. And Selling Expenses |
20.73 |
24.76 |
31.00 |
39.50 |
40.30 |
|
R & D Expenses |
-- |
-- |
-- |
-- |
-- |
|
Provisions And Contingencies |
-- |
-- |
-- |
-- |
-- |
|
Exp. Capitalised |
-- |
-- |
-- |
-- |
-- |
|
Other Expenses |
55.89 |
47.61 |
65.84 |
78.44 |
64.35 |
|
P/L Before Other |
55.14 |
42.24 |
59.85 |
39.56 |
16.82 |
|
Other Income |
7.36 |
6.84 |
6.15 |
9.51 |
6.78 |
|
P/L Before Int. |
62.51 |
49.07 |
66.00 |
49.07 |
23.60 |
|
Interest |
0.55 |
0.54 |
0.58 |
-- |
-- |
|
P/L Before Exceptional Items & Tax |
61.95 |
48.54 |
65.43 |
49.07 |
23.60 |
|
Exceptional Items |
-- |
-- |
-- |
-- |
-- |
|
P/L Before Tax |
61.95 |
48.54 |
65.43 |
49.07 |
23.60 |
|
Tax |
16.98 |
12.25 |
29.49 |
10.15 |
8.07 |
|
P/L After Tax from Ordinary Activities |
44.97 |
36.28 |
35.93 |
38.92 |
15.53 |
|
Prior Year Adjustments |
-- |
-- |
-- |
-- |
-- |
|
Extra Ordinary Items |
-- |
-- |
-- |
-- |
-- |
|
Net Profit/(Loss) For the Period |
44.97 |
36.28 |
35.93 |
38.92 |
15.53 |
|
Equity Share Capital |
5.00 |
5.00 |
5.00 |
5.00 |
5.00 |
|
Reserves Excluding Revaluation Reserves |
-- |
-- |
-- |
-- |
-- |
|
Equity Dividend Rate (%) |
-- |
-- |
-- |
-- |
-- |
|
EPS Before Extra Ordinary |
|
|
|
|
|
|
Basic EPS |
17.99 |
14.51 |
14.37 |
-- |
6.21 |
|
Diluted EPS |
17.99 |
-- |
14.37 |
-- |
6.21 |
|
EPS After Extra Ordinary |
|
|
|
|
|
|
Basic EPS. |
17.99 |
14.51 |
14.37 |
-- |
6.21 |
|
Diluted EPS. |
17.99 |
-- |
14.37 |
-- |
6.21 |
|
Public Share Holding |
|
|
|
|
|
|
No Of Shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
Share Holding (%) |
-- |
-- |
-- |
-- |
-- |
|
Promoters and Promoter Group Shareholding |
|
|
|
|
|
|
a) Pledged/Encumbered |
|
|
|
|
|
|
- Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
b) Non-encumbered |
|
|
|
|
|
|
- Number of shares (Crores). |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total sh. of prom. and promoter group). |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total Share Cap. of the company). |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited